Geriatrics | Page 14 of 63 | Links Medicus Content Curation & Alerts in Medicine

Our paper on associations between social health and cognitive decline led by @samtani_suraj in the SHARED consortium https://t.co/nZ9JKSY8Pg is now out in Lancet Healthy Longev followed by a brilliant commentary by Dr. Adam Roth at @OkStateSocio https://t.co/QVbG4IG4u3

— Anna Marseglia (@anna_marseglia_) October 21, 2022

Review | Equal but different! Improving care for older LGBT+ adults.

10 Nov, 2022 | 13:39h | UTC

Equal but different! Improving care for older LGBT+ adults – Age and Ageing (free for a limited period)

Review | New horizons in the ageing autonomic nervous system: orthostatic hypotension and supine hypertension.

10 Nov, 2022 | 13:37h | UTC

New horizons in the ageing autonomic nervous system: orthostatic hypotension and supine hypertension – Age and Ageing

Complexities of care: common components of models of care in geriatrics.

9 Nov, 2022 | 12:22h | UTC

Complexities of care: Common components of models of care in geriatrics – Journal of the American Geriatrics Society

Cohort Study | Population-based estimates of 1-year mortality after major surgery among community-living older adults.

9 Nov, 2022 | 12:23h | UTC

Population-Based Estimates of 1-Year Mortality After Major Surgery Among Community-Living Older US Adults – JAMA Surgery (link to abstract – $ for full-text)

Commentaries:

One in Seven Older Adults Die Within a Year After Surgery – Medscape (free registration required)

Surgery Holds Danger for Seniors. Who’s Most at Risk? – HealthDay

Commentary on Twitter

In a nationally representative sample of community-living Americans aged ≥65 years, nearly 1 out of every 7 persons died in the year after major surgery, including more than 1 of 4 who were frail and nearly 1 of 3 who had probable #dementia. https://t.co/nf8W4oLOLd @NHATS_NSOC

— JAMA Surgery (@JAMASurgery) October 19, 2022

Cohort Study | Association of hormone therapy with depression during menopause.

9 Nov, 2022 | 12:17h | UTC

Association of Hormone Therapy With Depression During Menopause in a Cohort of Danish Women – JAMA Network Open

Commentaries:

Expert reaction to study looking at HRT and depression during the menopause – Science Media Centre

Oral, Transdermal Hormone Therapy for Menopause Before Age 50 May Increase Risk of Depression – Psychiatric News Alert

Commentary on Twitter

Systemic hormone therapy (HT) before and during menopause is associated with higher risk of depression, especially in the years immediately after initiation; locally administered HT is associated with lower risk of depression for women ≥54 years. https://t.co/8k44K8SVtp

— JAMA Network Open (@JAMANetworkOpen) November 1, 2022

Cohort Study | Fracture risk among older cancer survivors compared with older adults without a history of cancer.

4 Nov, 2022 | 13:33h | UTC

Fracture Risk Among Older Cancer Survivors Compared With Older Adults Without a History of Cancer – JAMA Oncology (free for a limited period)

Commentary: Frailty-Related Fracture Risk Higher for Seniors With Cancer History – HealthDay

RCT | Post-operative electrical muscle stimulation may attenuate loss of muscle mass after abdominal surgery in older adults.

4 Nov, 2022 | 13:19h | UTC

Post-operative electrical muscle stimulation attenuates loss of muscle mass and function following major abdominal surgery in older adults: a split body randomised control trial – Age and Ageing

USPSTF Statement | Hormone therapy is not recommended for the prevention of chronic conditions in postmenopausal women.

3 Nov, 2022 | 14:19h | UTC

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement – JAMA

Editorial: Menopausal Hormone Therapy for Prevention of Chronic Conditions: When Is Enough, Enough? – JAMA

Evidence Report: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

JAMA Patient Page: Menopausal Hormone Therapy for Prevention of Chronic Conditions

Author Interview: USPSTF Recommendation: Hormone Therapy for Prevention of Postmenopausal Chronic Conditions – JAMA

Commentary: USPSTF: Hormone Therapy Not Advised for Primary Prevention of Chronic Conditions – HealthDay

Observational study suggests Apixaban for AF is associated with a lower risk of GI bleeding vs. other DOACs.

3 Nov, 2022 | 13:32h | UTC

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: Best blood thinner for minimizing bleeding risk identified – University College London

Commentary: GI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib – HealthDay

Sarcopenia definition, diagnosis and treatment: consensus is growing.

1 Nov, 2022 | 12:01h | UTC

Sarcopenia definition, diagnosis and treatment: consensus is growing – Age and Ageing

Singapore Clinical Practice Guidelines For Sarcopenia: Screening, Diagnosis, Management and Prevention – The Journal of Frailty & Aging

Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management – The journal of nutrition, health & aging

Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report – Age and Ageing

Brief Review | Preventing pressure injuries among patients in the intensive care unit.

1 Nov, 2022 | 11:50h | UTC

Preventing pressure injuries among patients in the intensive care unit: insights gained – Intensive Care Medicine

Commentary on Twitter

Preventing pressure injuries in #ICU
🎯 knowledge gains/prevention improvements: continuous bedside pressure mapping & prophylactic dressings
🎯 practical suggestions to alleviate PI development: using these as bundle may evidence greater effect#FOAMcc
📎 https://t.co/iGMun2A2PM pic.twitter.com/owgfAlfeqF

— Intensive Care Medicine (@yourICM) August 23, 2022

ACC Expert consensus for integrating atherosclerotic cardiovascular disease and multimorbidity treatment.

31 Oct, 2022 | 13:59h | UTC

2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee – Journal of the American College of Cardiology

Commentary: American College of Cardiology shares expert analysis on treating ASCVD patients with multiple chronic conditions – Cardiovascular Business

Commentary on Twitter

.@ACCinTouch's newest Expert Consensus Decision Pathway, just published in #JACC, offers a comprehensive and integrative framework for treating patients with #ASCVD and multimorbidity. https://t.co/NAa1aP4OEx #ACCClinicalDoc #CardioTwitter @kofi_larry @virani_md @tygluckman pic.twitter.com/XPePHSwuFL

— JACC Journals (@JACCJournals) October 25, 2022